We are live on ! Find out more
MLAB icon

Mesa Laboratories

107 hedge funds and large institutions have $585M invested in Mesa Laboratories in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

850% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 2

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

41% more capital invested

Capital invested by funds: $416M → $585M (+$169M)

18% more funds holding

Funds holding: 91107 (+16)

3% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 36

1.42% less ownership

Funds ownership: 74.19%72.78% (-1.4%)

Holders
107
Holders Change
+16
Holders Change %
+17.58%
% of All Funds
2.45%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
19
Increased
35
Reduced
36
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
FIM
76
Freedom Investment Management
Connecticut
$366K -$578K -3,303 -66%
SIM
77
Spark Investment Management
New York
$337K +$280K +1,600 New
EGM
78
Engineers Gate Manager
New York
$324K +$269K +1,535 New
MIM
79
MetLife Investment Management
New Jersey
$311K
VOYA Investment Management
80
VOYA Investment Management
Georgia
$299K -$22.6K -129 -8%
DTL
81
Dynamic Technology Lab
Singapore
$298K +$247K +1,410 New
KTC
82
Kistler-Tiffany Companies
Pennsylvania
$288K -$196K -1,119 -45%
PP
83
Paloma Partners
Connecticut
$284K +$235K +1,346 New
PNC Financial Services Group
84
PNC Financial Services Group
Pennsylvania
$251K -$196K -1,120 -49%
VF
85
Virtu Financial
New York
$248K +$206K +1,177 New
MLICM
86
Metropolitan Life Insurance Company (MetLife)
New York
$243K
GT
87
Glenmede Trust
Pennsylvania
$222K
D.E. Shaw & Co
88
D.E. Shaw & Co
New York
$222K +$184K +1,050 New
GWM
89
Geneos Wealth Management
Colorado
$153K
LTFS
90
Ladenburg Thalmann Financial Services
Florida
$147K
JP Morgan Chase
91
JP Morgan Chase
New York
$142K +$3.15K +18 +3%
Legal & General Group
92
Legal & General Group
United Kingdom
$122K +$4.2K +24 +4%
SA
93
SRH Advisors
Kansas
$106K
Citigroup
94
Citigroup
New York
$100K +$19.2K +110 +30%
Canada Life
95
Canada Life
Manitoba, Canada
$89K
Barclays
96
Barclays
United Kingdom
$51K -$76.6K -438 -65%
AIP
97
Ameritas Investment Partners
Nebraska
$49K
AG
98
Advisor Group
Arizona
$42K -$1.57K -9 -4%
BNP Paribas Financial Markets
99
BNP Paribas Financial Markets
France
$32.9K -$93.6K -535 -77%
Federated Hermes
100
Federated Hermes
Pennsylvania
$15K +$12.1K +69 New

MLAB Hedge Fund Activity: Q2 2018 in Review

107 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q2 2018, worth a combined $585M — up 41% from $416M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new MLAB positions and 2 closed out — a net gain of 17 holders — while 35 added to existing stakes and 36 trimmed.

The largest buyer was Massachusetts Financial Services, opening a new position worth an estimated $10M. The largest seller was Victory Capital Management, cutting an estimated $10.7M.

  • 107 institutional investors held Mesa Laboratories (MLAB) as of Q2 2018, up from 91 in Q1 2018.
  • Funds reported $585M of Mesa Laboratories stock for Q2 2018, up 41% quarter-over-quarter.
  • 19 funds opened new Mesa Laboratories positions in Q2 2018 and 2 closed out, a net change of +17 holders.
  • The largest Mesa Laboratories buyer in Q2 2018 was Massachusetts Financial Services, an estimated $10M added.
  • The largest Mesa Laboratories seller in Q2 2018 was Victory Capital Management, an estimated $10.7M sold.

Based on aggregated 13F filings for Q2 2018.